DaVita Clinical Research (DCR) is a full-service Phase I-IV renal clinical trial site and Site Management Organization. A subsidiary of DaVita, Inc., one of the largest providers of dialysis services in the United States, DCR has over 15 years of experience as a recognized leader in renal clinical trials for pharmaceutical drugs and devices. DCR is a private trial site located in Minneapolis, MN, with access to many local and national patient populations. Nationally, DCR has access to over 400 dialysis facilities and over 38,000 end-stage renal disease patients.

DaVita Clinical Research is committed to the success of customer's studies, by providing uncompromising quality and timely, cost-effective professional services. DCR is unique, providing Phase I-IV renal clinical trials/510(k) approval capabilities, quick local IRB approval, rapid enrollment of patients, and Board Certified physicians committed to quality management of all protocol research activities in areas such as:

• End-Stage Renal Disease (ESRD)
• Renal Insufficiency

Our center features:

• 55 beds for patient confinement
• Recreational amenities
• 24-hour medical coverage
• Private client monitor rooms
• Four exam rooms and two large treatment rooms
• Outpatient blood draw area
• Sample processing laboratory
• Freezers (-70 degree Celsius and -20 degree Celsius)
• Refrigerated centrifuges
• Computerized EKG machines
• Laminar flow hood for IV preparation
• Telemetry capabilities
• Access to hemodialysis units
• Registered dietitian consultant
• Specialty meals
• Affiliation with two CLIA certified clinical laboratories

DCR's headquarters and phase I unit are located in Downtown Minneapolis, MN, adjacent to Hennepin County Medical Center. We are a ten-minute drive from Minneapolis/St. Paul International Airport.

Harry Alcorn Jr. PharmD., Chief Scientific Officer;
DaVita Clinical Research
825 South 8th Street, Suite 300
Minneapolis, MN 55404
USA
888-345-2567
866-852-3241 (fax)
Halcorn@dcrmn.com
www.dcrmn.com